Ilico Genetics, a Spin Off of Pontificia Universidad Católica de Chile, is developing the first methylated DNA-based molecular test specifically designed for the early detection of gastric cancer, detecting cancer years before the industry gold standard, Upper Endoscopy (EGD).
With only a blood sample, their test detects a tumor in the stomach or lesions that could evolve into gastric cancer even without symptoms. The results are dynamic and show the cumulative presence of tumors over time.
